HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,658,666 | +5.1% | 3,567,781 | -0.1% | 0.29% | +7.0% |
| Q2 2023 | $304,183,677 | +0.4% | 3,572,871 | -2.4% | 0.27% | -3.2% |
| Q1 2023 | $302,910,086 | -0.6% | 3,661,736 | -5.5% | 0.28% | -6.0% |
| Q4 2022 | $304,657,155 | +5.7% | 3,873,436 | -0.5% | 0.30% | -0.7% |
| Q3 2022 | $288,209,000 | +18.9% | 3,893,389 | +4.7% | 0.30% | +23.4% |
| Q2 2022 | $242,426,000 | +1.8% | 3,718,844 | -1.3% | 0.24% | +20.8% |
| Q1 2022 | $238,238,000 | +16.1% | 3,769,086 | -2.8% | 0.20% | +25.5% |
| Q4 2021 | $205,218,000 | -23.9% | 3,876,521 | +0.5% | 0.16% | -31.8% |
| Q3 2021 | $269,677,000 | +8.2% | 3,856,498 | +2.6% | 0.24% | +8.8% |
| Q2 2021 | $249,142,000 | -20.6% | 3,760,310 | +32.5% | 0.22% | -27.7% |
| Q1 2021 | $313,849,000 | -6.5% | 2,837,486 | +0.2% | 0.30% | -13.8% |
| Q4 2020 | $335,642,000 | +33.4% | 2,833,049 | -1.9% | 0.35% | +16.8% |
| Q3 2020 | $251,659,000 | -9.4% | 2,888,690 | -6.9% | 0.30% | -13.6% |
| Q2 2020 | $277,693,000 | +4.8% | 3,101,345 | +16.6% | 0.34% | -14.6% |
| Q1 2020 | $264,992,000 | -11.7% | 2,658,957 | +1.8% | 0.40% | +15.4% |
| Q4 2019 | $300,110,000 | +5.2% | 2,611,916 | +15.5% | 0.35% | +0.6% |
| Q3 2019 | $285,257,000 | +8.8% | 2,261,433 | +3.8% | 0.35% | +10.8% |
| Q2 2019 | $262,294,000 | +84.5% | 2,179,611 | +34.1% | 0.31% | +80.5% |
| Q1 2019 | $142,176,000 | -0.1% | 1,625,242 | +14.2% | 0.17% | -12.1% |
| Q4 2018 | $142,355,000 | -16.0% | 1,422,836 | -3.8% | 0.20% | +3.1% |
| Q3 2018 | $169,500,000 | +24.6% | 1,479,314 | -2.4% | 0.19% | +28.0% |
| Q2 2018 | $136,007,000 | +6.9% | 1,515,638 | -12.8% | 0.15% | +3.4% |
| Q1 2018 | $127,279,000 | +12.6% | 1,738,933 | -10.6% | 0.14% | +11.5% |
| Q4 2017 | $113,061,000 | +22.7% | 1,945,422 | -5.3% | 0.13% | +13.0% |
| Q3 2017 | $92,139,000 | +25.2% | 2,053,458 | +10.2% | 0.12% | +21.1% |
| Q2 2017 | $73,596,000 | -9.7% | 1,863,661 | -7.2% | 0.10% | -9.5% |
| Q1 2017 | $81,476,000 | +11.1% | 2,008,284 | +10.1% | 0.10% | +7.1% |
| Q4 2016 | $73,324,000 | +7.6% | 1,823,981 | -3.1% | 0.10% | +6.5% |
| Q3 2016 | $68,140,000 | +22.2% | 1,881,814 | -2.2% | 0.09% | +19.5% |
| Q2 2016 | $55,774,000 | -31.4% | 1,923,909 | -17.2% | 0.08% | -31.2% |
| Q1 2016 | $81,288,000 | +5.6% | 2,323,856 | -2.7% | 0.11% | +10.9% |
| Q4 2015 | $76,974,000 | -35.9% | 2,387,525 | -35.8% | 0.10% | -34.8% |
| Q3 2015 | $120,156,000 | -30.0% | 3,717,686 | -10.4% | 0.16% | -18.8% |
| Q2 2015 | $171,670,000 | -15.6% | 4,150,626 | -8.3% | 0.19% | -12.0% |
| Q1 2015 | $203,334,000 | +11.1% | 4,526,580 | -7.4% | 0.22% | +14.2% |
| Q4 2014 | $182,973,000 | +1.6% | 4,889,723 | -5.1% | 0.19% | +2.7% |
| Q3 2014 | $180,003,000 | -7.6% | 5,154,730 | -6.7% | 0.18% | -2.6% |
| Q2 2014 | $194,839,000 | +5.3% | 5,522,650 | -2.7% | 0.19% | +1.1% |
| Q1 2014 | $185,008,000 | -23.3% | 5,676,833 | -0.8% | 0.19% | -24.2% |
| Q4 2013 | $241,191,000 | -48.5% | 5,724,923 | -38.4% | 0.25% | -11.4% |
| Q3 2013 | $467,967,000 | +83.3% | 9,288,936 | +50.5% | 0.28% | -7.9% |
| Q2 2013 | $255,291,000 | – | 6,173,902 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |